Simvastatin [orch, phsu]
Lymphocyte Function [bmod]
Secretory [celf]
Patients [podg]
Impaired fasting glucose [fndg]
Previous [tmco]
Study [mnob]
IMPACT [gngm]
Statins [orch, phsu]
Lymphocyte Function [bmod]
Secretory [celf]
Patients [podg]
early stages [tmco]
glucose metabolism [moft]
Abnormalities [cgab]
Study [mnob]
Strength [qnco]
Lymphocyte [cell]
suppressing [ftcn]
Simvastatin [orch, phsu]
Patients [podg]
Impaired fasting glucose [fndg]
Action [ftcn]
Dyslipidaemia [dsyn]
Subject [grup]
Phytohaemagglutinin [aapp, imft, irda]
Stimulated [npop]
Lymphocytes [cell]
Impaired fasting glucose [fndg]
N NOS [aapp, imft]
N 30 [orch, phsu]
Subject [grup]
Interleukin-2 [aapp, imft]
Interferon Gamma [aapp, imft, phsu]
tumor necrosis factor-alpha [aapp, imft]
Lymphocytes [cell]
matched [resa]
Subject [grup]
Normal plasma [bdsu]
Lipids [lipd]
Glucose tolerance [phsf]
lowering [spco]
Plasma lipids [lbpr]
treatment [ftcn]
Group [idcn]
Simvastatin [orch, phsu]
mg% [qnco]
Daily [tmco]
Reduced [qlco]
Lymphocyte [cell]
cytokine [aapp, imft]
Release [hlca]
Observed [ftcn]
Subject [grup]
Decrease [qlco]
Plasma C-reactive protein [aapp]
High sensitivity [lbpr]
soluble [celc]
Intercellular adhesion molecule 1 [aapp, imft]
Levels [qlco]
Study [mnob]
early stages [tmco]
glucose metabolism [moft]
Abnormalities [cgab]
Lymphocyte Function [bmod]
Secretory [celf]
Degree [qlco]
Hypercholesterolaemia [dsyn]
Simvastatin [orch, phsu]
effective [qlco]
Lymphocyte [cell]
suppressing [ftcn]
Anti-inflammatory agent [phsu]
plasma lipid [lbpr]
treatment [ftcn]
Induced [ftcn]
reduction [npop]
Lymphocyte [cell]
cytokine [aapp, imft]
Release [hlca]
Systemic [ftcn]
Inflammation [patf]
Contribute [acty]
Effectiveness [qlco]
Statins [orch, phsu]
Prevention [topp]
therapy [ftcn]
Atherosclerosis [dsyn]
Subject [grup]
glucose metabolism [moft]
Abnormalities [cgab]
Dyslipidaemia [dsyn]
